Press Releases
Search
-
23 Apr 2014
First-Quarter 2014 Business Review
Sales: Up 7.9%, including BioFire and at constant exchange rates Up 4.1% like-for-like*, in line with the target for the year Continued stabilization in Western Europe, up 1.4%* Sustained solid growth...
-
15 Apr 2014
Alexandre Mérieux Assumes Role of bioMérieux CEO
Marcy l’Etoile (France), April 15, 2014 - Alexandre Mérieux will take on the role of Chief Executive Officer of bioMérieux and head its Management Committee. To step up the rollout of its strategic pl...
-
19 Mar 2014
bioMérieux - 2013 Financial Results
HIGHLIGHTS Objectives met Solid financial performance Sales up 4.6% at constant exchange rates and scope of consolidation Operating income before non-recurring items: €262 million, or 16.5% of sales F...
-
26 Feb 2014
bioMérieux strengthens its Clostridium difficile offer with the launch of VIDAS® C. difficile GDH
VIDAS® C. difficile GDH is the 100th assay for use on VIDAS® range VIDAS® C. difficile GDH is the only FDA-approved automated immunoassay parameter for GDH* detection * Glutamate dehydrogenase...
-
19 Feb 2014
BioFire Submits 510(k) Application to FDA for FilmArray® Gastrointestinal Panel
BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The comprehensive FilmArra...
-
27 Jan 2014
Appointment of Claire Giraut as bioMérieux’s Corporate Vice President & Chief Financial Officer
Marcy l’Etoile, France, January 27, 2014 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that Claire Giraut has been appointed Corporate Vice President & Chief Financial O...